Nasal secretion analysis in allergic rhinitis, cystic fibrosis, and nonallergic fibromyalgia/chronic fatigue syndrome subjects
- PMID: 9883301
- DOI: 10.2500/105065898780707964
Nasal secretion analysis in allergic rhinitis, cystic fibrosis, and nonallergic fibromyalgia/chronic fatigue syndrome subjects
Abstract
Rhinitis symptoms are present in approximately 70% of subjects with fibromyalgia and chronic fatigue syndrome (FM/CFS). Because only 35% to 50% have positive allergy skin tests, nonallergic mechanisms may also play a role. To better understand the mechanisms of nonallergic rhinitis in FM/CFS, nasal lavages were performed, and markers of vascular permeability, glandular secretion, and neutrophil and eosinophil infiltration measured in 27 nonallergic FM/CFS, 7 allergic rhinitis, 7 cystic fibrosis, and 9 normal subjects. Allergic rhinitis subjects had significantly increased vascular permeability (IgG) and ECP levels. Cystic fibrosis subjects had significantly higher elastase and total protein levels. There were no significant differences between FM/CFS and normal lavage fluids. Analysis of the constituents of nasal mucus provides information about ongoing secretory processes in rhinitis. There were no differences in the basal secretion of these markers of vascular permeability, submucosal gland serous cell secretion, eosinophil and neutrophil degranulation in nonallergic FM/CFS subjects. This suggests that constitutively active secretory processes that regulate continuous production of nasal secretions are not altered in FM/CFS. Future studies should examine alternative mechanisms such as inducible, irritant-activated, or reflex-mediated effects.
Similar articles
-
Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum.Clin Exp Allergy. 1994 Dec;24(12):1151-6. doi: 10.1111/j.1365-2222.1994.tb03321.x. Clin Exp Allergy. 1994. PMID: 7889429
-
Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis.Eur Respir J. 1999 Mar;13(3):633-7. doi: 10.1183/09031936.99.13363399. Eur Respir J. 1999. PMID: 10232439 Clinical Trial.
-
Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.Laryngoscope. 2000 Jun;110(6):1056-62. doi: 10.1097/00005537-200006000-00031. Laryngoscope. 2000. PMID: 10852530
-
Nasal nitric oxide and nasal allergy.Allergy. 2006 Jun;61(6):665-70. doi: 10.1111/j.1398-9995.2006.01096.x. Allergy. 2006. PMID: 16677234 Review.
-
Allergic rhinitis and vascular endothelial growth factor.J Nippon Med Sch. 2012;79(3):170-5. doi: 10.1272/jnms.79.170. J Nippon Med Sch. 2012. PMID: 22791116 Review.
Cited by
-
Chronic fatigue syndrome: the need for subtypes.Neuropsychol Rev. 2005 Mar;15(1):29-58. doi: 10.1007/s11065-005-3588-2. Neuropsychol Rev. 2005. PMID: 15929497 Review.
-
The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: exploration of a shared pathophysiology.J Pain Res. 2018 Dec 10;11:3129-3140. doi: 10.2147/JPR.S186878. eCollection 2018. J Pain Res. 2018. PMID: 30573989 Free PMC article.
-
Prevalence and differential diagnosis of chronic rhinitis.Curr Allergy Asthma Rep. 2001 May;1(3):202-6. doi: 10.1007/s11882-001-0006-6. Curr Allergy Asthma Rep. 2001. PMID: 11892037 Review.
-
Mechanisms of allergic rhinitis.Curr Allergy Asthma Rep. 2001 May;1(3):207-17. doi: 10.1007/s11882-001-0007-5. Curr Allergy Asthma Rep. 2001. PMID: 11892038 Review.